Related Experiment Video

Updated: Jun 19, 2026

Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry
08:07

Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry

Published on: July 26, 2019

Regulation of insulin secretion by phosphatidylinositol-4,5-bisphosphate

Alejandra Tomas1, Barbara Yermen, Romano Regazzi

  • 1Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland. Alejandra.TomasCatala@unige.ch

Traffic (Copenhagen, Denmark)
|October 23, 2009
PubMed

Insights

Phosphatidylinositol 4,5-bisphosphate (PIP(2)) enhances pancreatic beta cell survival but excessive levels inhibit insulin secretion by disrupting actin and endocytic recycling. This study clarifies PIP(2)'s dual role in beta cell function.

Area of Science:

  • Cell Biology
  • Endocrinology
  • Molecular Biology

Background:

  • Phosphatidylinositol 4,5-bisphosphate (PIP(2)) is crucial for various cellular processes.
  • Its specific role in pancreatic beta cell function, particularly insulin secretion and survival, requires further elucidation.

Purpose of the Study:

  • To investigate the role of PIP(2) in pancreatic beta cell function using the MIN6B1 cell line.
  • To determine how manipulating PIP(2) levels affects glucose-stimulated insulin secretion and cell survival.

Main Methods:

  • Utilized MIN6B1 beta cell line.
  • Manipulated PIP(2) levels using PH-PLC-GFP and PIP5KIgamma RNAi/overexpression.
  • Assessed glucose-stimulated secretion, apoptosis, and endocytic pathways.
  • Investigated protein co-localization (e.g., PIP(2), Arf6, gelsolin, F-actin, phogrin).

Main Results:

  • Blocking PIP(2) increased apoptosis but did not affect secretion.
  • PIP5KIgamma overexpression improved survival, inhibited secretion, and caused vacuole accumulation with F-actin and endocytic markers.
  • Arf6 activation mimicked PIP5KIgamma overexpression effects on secretion and vacuoles.
  • PIP(2) co-localized with F-actin and gelsolin; gelsolin partially rescued secretion defects.
  • RhoA/ROCK pathway inhibition promoted secretion, an effect blocked by PIP5KIgamma overexpression.

Conclusions:

  • PIP(2) plays a pro-survival role in pancreatic beta cells.
  • Excessive PIP(2) inhibits insulin secretion via impaired Arf6-dependent endocytic recycling and RhoA/ROCK-dependent F-actin cytoskeleton disruption.

More Related Videos

Single-molecule Super-resolution Imaging of Phosphatidylinositol 4,5-bisphosphate in the Plasma Membrane with Novel Fluorescent Probes07:26

Single-molecule Super-resolution Imaging of Phosphatidylinositol 4,5-bisphosphate in the Plasma Membrane with Novel Fluorescent Probes

Published on: October 15, 2016

Absolute Quantitation of Inositol Pyrophosphates by Capillary Electrophoresis Electrospray Ionization Mass Spectrometry09:22

Absolute Quantitation of Inositol Pyrophosphates by Capillary Electrophoresis Electrospray Ionization Mass Spectrometry

Published on: August 13, 2021

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...